South Sudan vs Vanuatu: The number of people with susceptibility test result for rifampicin
South Sudan
0
in 2021
Vanuatu
0
in 2021
South Sudan rank
142nd
Vanuatu rank
142nd
The number of people with susceptibility test result for rifampicin over time
- South Sudan
- Vanuatu
How they compare
South Sudan currently reports 0 against 0 in Vanuatu, a difference of 0.
Across all 5 years both countries report, Vanuatu has been ahead every year.
South Sudan ranks 142nd and Vanuatu ranks 142nd of 146 countries.
Vanuatu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.82 | 99.29 | 97.47 | Vanuatu |
| 2020s | 2.31 | 46.74 | 44.43 | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, South Sudan or Vanuatu?
- South Sudan, at 0 against 0 in Vanuatu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between South Sudan and Vanuatu?
- 0, with South Sudan ahead.
- How many years of comparable data are there for South Sudan and Vanuatu?
- 5 years are reported by both, from 2017 to 2021.
- How do South Sudan and Vanuatu rank globally for the number of people with susceptibility test result for rifampicin?
- South Sudan ranks 142nd and Vanuatu ranks 142nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.